In CRC liver metastases, however, TSP-1 expression has been linked to significantly poorer survival, suggesting that TSP-1 in liver metastases may have an alternative mode of action, facilitating tumour invasion rather than acting as an anti-angiogenic growth factor [51]. This evidence concerns the gene THBS1 and neoplasm.